Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Unknown 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 3

Conditions

Hydatidiform Mole 3Gestational Trophoblastic Disease 3Trophoblastic Neoplasms 1

Interventions

Methotrexate 6Dactinomycin 6Drug Therapy 4camrelizumab 3Vacuum Curettage 3Flow Cytometry 3toripalimab 2pembrolizumab 2apatinib 2Psychiatric Rehabilitation 2Methylprednisolone 2Leucovorin 2Immunologic Techniques 2Filgrastim 2Etoposide 2Cyclophosphamide 2Carboplatin 2Alemtuzumab 2zimberelimab 1sargramostim 1dostarlimab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carotuximab 1aldesleukin 1Vincristine 1Thrombopoietin 1Tacrolimus 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Gestational Trophoblastic Disease × Vacuum Curettage × Clear all
NCT05203562 2022-07-12

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Zagazig University

Phase 2/3 Unknown
200 enrolled
Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT04756713 2022-05-27

ReCure

Brigham and Women's Hospital

Phase 3 Unknown
150 enrolled
Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT00166790 2014-12-08

Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease

National Taiwan University Hospital

Unknown
30 enrolled
Gynecologic

Trophoblastic Neoplasms, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡